All these findings suggest that GSTP1 overexpression, beyond its role in drug resistance, may contribute to the metastatic ability of cancers including promoting EMT, modulating MMPs, and upregulating certain signaling pathways, thus becoming an attractive target for metastasis research. The gene discussed is GSTP1; the disease is cancer.